The Fresh Toast

DECEMBER 16, 2021

Whole Plant Medicinal Cannabis Could Be More Effective Than CBD In Epilepsy Treatment. The post Whole Plant Medicinal Cannabis Could Be More Effective Than CBD In Epilepsy Treatment appeared first on The Fresh Toast. Whole plant cannabis includes THC, CBD, and other neuroactive molecules such as terpenes.

Epilepsy 98

Epilepsy Treatment Medicine CBD 98

NORML

JULY 12, 2021

The lawsuit, which was filed by a 19-year-old patient who uses cannabis for the treatment of severe epilepsy, argues that the proposed changes will unduly restrict medical cannabis access among patients and will discourage physicians from participating in the program.

Epilepsy 242

Epilepsy Legalization Treatment Patients 242

Leafwell

SEPTEMBER 23, 2021

The past few years have seen a huge surge in interest in using cannabis – in particular, the cannabinoid, cannabidiol (CBD) – for epilepsy. Furthermore, Epidiolex, a mostly CBD-based medication, has been approved by the FDA for the treatment of Dravet and Lennox-Gastaut Syndrome, both severe forms of epilepsy.

Epilepsy 91

Epilepsy CBD Treatment Cannabinoids 91

United Patients Group

JANUARY 30, 2023

The Benefits of Cannabis in the Treatment of Myasthenia Gravis Introduction Myasthenia gravis ( MG ) is a rare autoimmune disease that affects the nerves and muscles. Doctors usually treat MG with thymectomies, immunomodulating drugs, acetylcholinesterase inhibitors and IV immunoglobulin treatments. Could marijuana be the answer?

Treatment 134

Treatment Cannabinoids Blood Pressure Patients 134

Illinois News Joint

JANUARY 9, 2025

Providers are now able to begin certifying patients with those conditions for treatment with medical cannabis. The post IDPH approves four new conditions for medical cannabis treatment appeared first on Illinois News Joint. Those four newly added conditions bring the total to 56. For Illinois News Joint reviews, visit here.

Conditions 105

Conditions Treatment Chronic Pain Epilepsy 105

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

In either case, there is definitely a connection, and the widening availability for adults to consume cannabis legally for recreational and medicinal purposes has driven public interest into using cannabis for mental health treatment. Between CBD and THC, CBD seems to hold the best potential as a treatment for anxiety compared to THC.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Cannabis Law Report

JUNE 1, 2021

.” It is still an oddity in Australia but in many US states, medicinal cannabis medications including tetrahydrocannabinol (THC) — the psychoactive component in cannabis — are being used as a treatment for pets with conditions such as arthritis and epilepsy. It is a big and growing business. Read the full article at [link].

Treatment 105

Treatment Pets Epilepsy Cannabinoids 105

Veriheal

AUGUST 12, 2021

Patients who suffer from epilepsy , which affects some 3.4 This is according to a recently published study featured in the peer-reviewed journal Epilepsy & Behavior. This is according to a recently published study featured in the peer-reviewed journal Epilepsy & Behavior. CBD, which constitutes a $2,770.8

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

Cannabis Law Report

AUGUST 26, 2022

CBD has been suggested to act as a treatment for sclerosis symptoms, as well as epilepsy among children. Seizures and epilepsy are serious medical conditions. Epilepsy is a central nervous system disorder that involves the brain making people more susceptible to recurrent unprovoked seizures. billion by the year 2028.

Epilepsy 52

Epilepsy Treatment CBD Sleep 52

Cannabis Law Report

AUGUST 10, 2021

We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

MAY 31, 2023

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has passed a significant milestone, delivering the first doses of its CannEpil® units to patients in the United Kingdom, paving the way for the treatment of refractory epilepsy, an unmet need in the country.

Epilepsy 52

Epilepsy Pharmaceutical Treatment Patients 52

MMJ Recs

NOVEMBER 20, 2023

Epilepsy Management: CBD, in particular, has emerged as an effective treatment for epilepsy, especially in individuals with rare and severe forms of the condition. Neurological Disorders: Several cannabinoids show promise in the treatment of neurological disorders, including multiple sclerosis (MS) and Parkinson’s disease.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

MedicalJane

NOVEMBER 10, 2020

A newly published article in the Epilepsy & Behavior Journal highlights the findings of researchers at the University of Alabama at Birmingham after surveying healthcare providers on their attitudes and knowledge about cannabis, and has confirmed what most of us already knew– healthcare providers need more education on cannabis.

Education 122

Education Epilepsy Therapy Patients 122

MGC Pharma

NOVEMBER 1, 2017

CannEpil™ is CBD-based medication that is used as a treatment for people with refractory epilepsy. We have been working hard testing the effects of CBD on patients with epilepsy, with our advisory team, Professor Uri Kramer and Professor David Neubauer, for the past two years.

Epilepsy 100

Epilepsy Pharmaceutical Medicine CBD 100

Cannabis Law Report

AUGUST 23, 2021

Phase II clinical trial of the Satipharm CBD capsules showed significantly reduced monthly seizure frequency in the treatment of children suffering from refractory, or treatment-resistant epilepsy when the Satipharm capsules were added to current medications. following 12 weeks of treatment.

Clinical Trials 105

Clinical Trials CBD Epilepsy Treatment 105

Veriheal

SEPTEMBER 16, 2020

Epidiolex was approved specifically for treating patients suffering from seizures associated with Dravet Syndrome, which is a severe form of epilepsy that affects between 20,000 and 40,000 people worldwide. The FDA Adds a New Condition for Treatment. So why limit the use of Epidiolex to just this one condition?

Access 98

Access Epilepsy Treatment Conditions 98

Cannabis Law Report

JULY 30, 2019

The use of medicinal cannabis by children is currently restricted to children with autism or severe epilepsy in which conventional treatment does not improve their condition. However, it is already apparent that new price levels will harm people requiring more than 30 to 40 grams a month.

Treatment 91

Treatment Medicine Epilepsy Extraction 91

United Patients Group

JULY 7, 2023

3) Helps Manage Nausea and Vomiting Medical cannabis can be used to manage nausea and vomiting associated with chemotherapy, radiation therapy, and other medical treatments. Nausea and vomiting are common side effects of these treatments and can significantly impact a person’s quality of life.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

Medical Marijuana Program Connection

JANUARY 5, 2024

January 05, 2024 2 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on. “ data-action=”subscribe”> Subscribe We were unable to process. Read More

Epilepsy 49

Epilepsy Treatment Topical Data 49

CannaMD

MARCH 29, 2023

Florida law allows eligible residents to receive medical marijuana treatment for specific medical issues, including ALS, cancer, Crohn’s Disease, Epilepsy, Glaucoma, HIV/AIDS, Multiple Sclerosis, Parkinson’s Disease, PTSD, and more.

Patients 98

Patients Epilepsy Marijuana Treatment 98

MGC Pharma

APRIL 4, 2018

CBD-based treatment for people with Refractory Epilepsy?—?is According to the World Health Organisation (WHO), there are approximately 50 million people currently living with a form of Epilepsy throughout the world, and of those 50 million, 30% have Refractory Epilepsy. CannEpil™?—?CBD-based

Epilepsy 100

Epilepsy Pharmaceutical Research and Development CBD 100

Medical Marijuana Program Connection

MARCH 6, 2023

Researchers at Aston University have contributed to the discovery of a previously unknown way in which cannabidiol (CBD), a non-psychoactive. Read More

Epilepsy 52

Epilepsy Treatment CBD Medicine 52

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. tetrahydrocannabinol (THC).

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Veriheal

MARCH 2, 2024

In December of 2023, the country recently made a new move towards reform that could stimulate the cannabidiol (CBD) industry and provide many patients, such as those with epilepsy , with access to potentially life-changing medical treatments. and Europe to treat severe epilepsy, as well as other medical conditions.

Legalization 110

Legalization Epilepsy Clinical Trials THC 110

Cannabis Law Report

AUGUST 5, 2021

Previously, Tennessee law allowed only those diagnosed with intractable seizures or epilepsy to possess a limited amount of medical cannabis oil. Cancer, when such disease is diagnosed as end-stage or the treatment produces related wasting illness, nausea and vomiting, or pain. Epilepsy or seizures. of THC: Alzheimer’s disease.

Law 105

Law Epilepsy Marijuana Oil 105

MMJ Recs

DECEMBER 28, 2023

In recent years, a significant shift has occurred in the perception of medical marijuana, transforming it from a controversial substance to a recognized and, in some places, a legal form of medical treatment. Epidiolex, a CBD-based medication, has even received FDA approval for the treatment of specific seizure disorders.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

Cannabis Law Report

JULY 27, 2021

and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Under the Leadership of Nicolas Schlienz, Ph.D., COLORADO SPRINGS, Colo.–(BUSINESS

Data 81

Data Epilepsy Research and Development Clinical Trials 81

MGC Pharma

FEBRUARY 15, 2018

A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals Right now in Australia, access to Cannabis-based treatments is heavily restricted. Physicians who want to prescribe Medicinal Cannabis are required to jump through countless regulatory hoops, as are patients seeking treatment.

Access 100

Access Medicine Chronic Pain Research and Development 100

Puff Puff Post

OCTOBER 3, 2019

Previous success from treating epilepsy with Cannabinoids now motivates doctors to investigate the plant’s effectiveness in treating symptoms of autism. Epidiolex is a CBD-infused oral-based medication designed to help patients as young as two-years-old treat epilepsy disorders.

Research and Development 94

Research and Development Epilepsy Clinical Trials Treatment 94

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. CBG, however, also has some medicinal potential that CBD doesn’t, for instance as a treatment for hypertension and insulin resistance. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

CannaMD

DECEMBER 16, 2020

To find out if you qualify for medical marijuana treatment, call (855) 420-9170 or fill out an easy online application ! To stay up-to-date with the latest studies and legal regulations surrounding medical marijuana treatment, be sure to follow CannaMD on Facebook and sign up for our newsletter, below! Alzheimer’s disease.

Marijuana 119

Marijuana Epilepsy Treatment Safety 119

Medical Marijuana Program Connection

JUNE 29, 2023

CBD oil has gained popularity in recent years as a potential treatment… var mantis = mantis || []; mantis.push(['display', 'load', { property: '5bbb53a2bcafb20075d8dc64' }]); Disclaimer: This post contains affiliate links.

Epilepsy 52

Epilepsy Oil CBD Treatment 52

Veriheal

DECEMBER 17, 2021

The study consisted of 10 different children who had previously been unresponsive to traditional seizure treatments. During this period, researchers tracked the children’s seizure frequency, changes in epilepsy drug use, and the cost of the cannabis products being used. The children were put on a daily medical cannabis regimen of 5.15

Dispensary 98

Dispensary Epilepsy Programs Treatment 98

CannaMD

AUGUST 6, 2020

Children with epilepsy don’t quit having seizures because they’re on vacation. As a state, Florida either acknowledges marijuana’s validity as a medically useful treatment or it doesn’t. Click to Sign Petition. Cancer symptoms don’t stop when patients cross state lines. Click to Sign Petition. Get Started.

Law 116

Law Marijuana Treatment Patients 116

Leaf Science

FEBRUARY 19, 2019

When using mice who had been selectively bred to develop symptoms associated with depression (such as lethargy and immobility), researchers found that CBD treatment was linked to a reduction in immobility during a forced swim test, a commonly used test used to study depressive symptoms. CBD is ripe to tackle depression.

CBD 101

CBD Research and Development Treatment Epilepsy 101

MMJ Recs

NOVEMBER 2, 2023

Patients across the state are turning to MMJ as a complementary or alternative treatment to alleviate symptoms and improve their quality of life. Seizure Control: Patients, especially children with epilepsy, are experiencing fewer and less severe seizures thanks to MMJ treatments.

Patients 98

Patients Chronic Pain Therapy Treatment 98

Cannabis Law Report

AUGUST 20, 2021

SLSG and its Swiss subsidiary, Savim SA , are developing specific proprietary strains of cannabis, with a focus on various areas, but particularly on future medical treatments for a variety of illnesses and diseases, including epilepsy, autism, and the different stages of COVID-19.

Research and Development 116

Research and Development Strains Treatment Epilepsy 116